You searched for Antibody candidate - Page 12 of 67

News and Trends 12 Dec 2024

Top biotech deals of November 2024

…part of this wintry time. Moreover, biotech deals in antibody-drug conjugates, small molecules, antibody therapies, GLP-1 agonists, and precision medicine stood out in November 2024. Table of contents Top M&As…

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 6 Mar 2025

Top biotech deals of February 2025

…$2.15 billion in milestone payments, with Novartis having paid $925 million upfront. Anthos will hand over its monoclonal antibody program, which is in the clinic to prevent stroke and systemic…

March 6, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 26 Oct 2016

Can this new Antibody-Drug Conjugate Collaboration make it to the Top?

Nordic Nanovector is collaborating with Heidelberg Pharma to access the promising antibody-drug conjugate (ADC) technology. However, can it really take on the strong competition? Nordic Nanovector develops antibody-radionuclide conjugates (ARCs)…

October 26, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Aug 2025

Top biotech deals in July 2025

…will secure LaNova’s lead candidate, an antibody-drug conjugate (ADC) called LM-302, which is in the clinic to treat gastric cancer and pancreatic ductal adenocarcinoma – the most common type of…

August 8, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 2 Nov 2017

Swiss Biotech Gets €12M as its Alzheimer’s Candidate Enters Phase II

…antibody’s efficacy and safety. AC Immune’s anti-Tau monoclonal antibody is based on the company’s SupraAntigen technology. They are generated by injecting the SupraAntigen constructs into mice and selecting antibodies that…

November 2, 2017 - 2 minutesmins - By Alex Dale

In Depth 4 Feb 2025

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

…the problems faced with getting small molecules to bind to these targets have been addressed, making sotorasib the first KRAS inhibitor to be approved in 2021. Now, candidates like divarasib…

February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter

News and Trends 23 Mar 2023

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

German biopharma BioNTech has closed a licensing deal with the U.S.-based clinical-stage company OncoC4 for the development and commercialization of the latter’s lead candidate ONC-392, for the treatment of cancer….

March 23, 2023 - 2 minutesmins - By Roohi Mariam Peter

Best in Biotech 22 Aug 2024

Seven companies transforming the biotech industry in Italy

…Among them is a vaccine for malaria, which has received significant attention and funding, including $12.2 million from the EU Malaria Fund. Another prominent candidate is MAbCo19, a monoclonal antibody…

August 22, 2024 - 9 minutesmins - By Jules Adam

In Depth 19 Mar 2025

Breast cancer treatments heat up: Five therapies poised to transform patient outcomes

…in 2023, in which BioNTech paid $55 million upfront for the rights to the candidate outside of greater China. The candidate in question is a bispecific antibody called BNT327 that…

March 19, 2025 - 11 minutesmins - By Willow Shah-Neville

Best in Biotech 5 Mar 2025

Seven biotech companies keeping Taiwan dynamic in 2025

…to enter the U.S. market in over 15 years. OBI Pharma Technology: Antibody-drug conjugate (ADC) platform targeting TROP2 Lead candidate: OBI-992 Recent news: Received FDA orphan drug designation for OBI-992…

March 5, 2025 - 8 minutesmins - By Jules Adam

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…RNA (mRNA) molecules, leading to mRNA degradation or inhibition of protein translation. Several companies are advancing candidates relying on miRNAs in 2024. miRNAs have garnered significant attention due to their…

November 26, 2024 - 9 minutesmins - By Jules Adam

News and Trends 14 Nov 2016

Ask the Biotech Recruiter: Time-Saving Tricks to Reel in a New Hire

…never had to write one before. Conversely, an attractive CV could hide a candidate’s lack of experience or exaggerations. For instance, did the candidate lead a project or merely participate…

November 14, 2016 - 6 minutesmins - By External Contributor

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Top biotech deals of November 2024

Top biotech deals of February 2025

Can this new Antibody-Drug Conjugate Collaboration make it to the Top?

Top biotech deals in July 2025

Swiss Biotech Gets €12M as its Alzheimer’s Candidate Enters Phase II

World Cancer Day: trends in cancer therapeutics to look forward to in 2025

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

Seven companies transforming the biotech industry in Italy

Breast cancer treatments heat up: Five therapies poised to transform patient outcomes

Seven biotech companies keeping Taiwan dynamic in 2025

Seven miRNA-focused companies pioneering new therapies in 2024

Ask the Biotech Recruiter: Time-Saving Tricks to Reel in a New Hire

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!